Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil
Ronaldo da Silva Francisco, L. Felipe Benites, Alessandra P. Lamarca, et al.
Virus Research (2021) Vol. 296, pp. 198345-198345
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
Science (2021) Vol. 372, Iss. 6544, pp. 815-821
Open Access | Times Cited: 1435
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2384-2393.e12
Open Access | Times Cited: 991
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
An overview of current COVID-19 vaccine platforms
Abdou Nagy, Bader Y. Alhatlani
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2508-2517
Open Access | Times Cited: 152
Recombination in Coronaviruses, with a Focus on SARS-CoV-2
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 96
Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France
Philippe Colson, Pierre‐Edouard Fournier, Jérémy Delerce, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3739-3749
Open Access | Times Cited: 67
Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples
Orsolya Pipek, Anna Medgyes‐Horváth, József Stéger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Intra-host evolution during SARS-CoV-2 prolonged infection
Carolina Moreira Voloch, Ronaldo da Silva Francisco, Luiz Gonzaga Paula de Almeida, et al.
Virus Evolution (2021) Vol. 7, Iss. 2
Open Access | Times Cited: 86
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact
Natali Vega‐Magaña, R. Sánchez Sánchez, Jorge Hernández‐Bello, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 72
SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
Uddhav Timilsina, Supawadee Umthong, Emily B. Ivey, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 48
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Giuseppe Novelli, Michela Biancolella, Ruty Mehrian‐Shai, et al.
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 53
The challenges of COVID‐19 Delta variant: Prevention and vaccine development
Xuemei He, Cai He, Weiqi Hong, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 846-854
Open Access | Times Cited: 49
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González‐Estevez, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 44
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma
Current Opinion in Pharmacology (2021) Vol. 62, pp. 64-73
Open Access | Times Cited: 43
Unusual SARS-CoV-2 intrahost diversity reveals lineage superinfection
Filipe Zimmer Dezordi, Paola Cristina Resende, Felipe Gomes Naveca, et al.
Microbial Genomics (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 31
Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages
Hangyu Zhou, Ye‐Xiao Cheng, Lin Xu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4015-4024
Open Access | Times Cited: 27
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
Xuemei He, Cai He, Weiqi Hong, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 932-971
Open Access | Times Cited: 17
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials
Wenping Gong, Ashok Aspatwar, Shuyong Wang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 7, pp. 857-880
Open Access | Times Cited: 37
Evolution of the SARS-CoV-2 genome and emergence of variants of concern
Iman Safari, Elahe Elahi
Archives of Virology (2021) Vol. 167, Iss. 2, pp. 293-305
Open Access | Times Cited: 36
CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern
Yuanhao Liang, Hongqing Lin, Lirong Zou, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 34
Culture and identification of a “Deltamicron” SARS-CoV-2 in a three cases cluster in southern France
Philippe Colson, Pierre‐Edouard Fournier, Jérémy Delerce, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Do pathogens always evolve to be less virulent? The virulence–transmission trade-off in light of the COVID-19 pandemic
Ádám Kun, András G. Hubai, Adrienn Král, et al.
Biologia Futura (2023) Vol. 74, Iss. 1-2, pp. 69-80
Open Access | Times Cited: 13
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top